http://www.unboundmedicine.com/medline/ebm/research/ifosfamideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19889622/full_citation/Salvage_chemotherapy_with_alternating_MINE_ESHAP_regimen_in_relapsed_or_refractory_Hodgkin's_lymphoma_followed_by_autologous_stem_cell_transplantation_Fernández de Larrea C, Martínez C, Gaya A, et al. 
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887304/full_citation/Association_of_pegylated_liposomal_doxorubicin_and_ifosfamide_in_early_recurrent_ovarian_cancer_patients:_A_Multicenter_Phase_II_Trial_Joly F, Sevin E, Lortholary A, et al. 
Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial. [JOURNAL ARTICLE]
Gynecol Oncol 2009 Nov 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886558/full_citation/Small_cell_osteosarcoma:_a_case_report_Kallel R, Ayadi L, Toumi N, et al. 
Small cell osteosarcoma: a case report. [Journal Article]
Pathologica 2009 Apr; 101(2):101-4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884539/full_citation/Phase_II_Trial_of_Concurrent_Radiation_and_Weekly_Cisplatin_Followed_by_VIPD_Chemotherapy_in_Newly_Diagnosed_Stage_IE_to_IIE_Nasal_Extranodal_NK/T_Cell_Lymphoma:_Consortium_for_Improving_Survival_of_Lymphoma_Study_Kim SJ, Kim K, Kim BS, et al. 
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19880438/full_citation/Factors_affecting_the_outcome_of_patients_with_metastatic_leiomyosarcoma_treated_with_doxorubicin_containing_chemotherapy_Penel N, Italiano A, Isambert N, et al. 
Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy. [JOURNAL ARTICLE]
Ann Oncol 2009 Oct 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19856869/full_citation/Early_development_of_acute_myeloid_leukemia_following_treatment_of_osteosarcoma:_a_case_report_and_review_of_the_literature_Shen YM, Hung GY, Yen HJ, et al. 
Early development of acute myeloid leukemia following treatment of osteosarcoma: a case report and review of the literature. [Journal Article]
Pediatr Neonatol 2009 Oct; 50(5):239-44.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19856674/full_citation/Ifosfamide_encephalopathy_and_use_of_methylene_blue__A_case_report_of_different_sequential_neurotoxicity_Giovanis P, Garna A, Marcante M, et al. 
Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity. [Journal Article]
Tumori 2009 Jul-Aug; 95(4):545-6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19856053/full_citation/Salvage_chemotherapy_with_paclitaxel_and_gemcitabine_plus_nedaplatin__TGN__as_part_of_multidisciplinary_therapy_in_patients_with_heavily_pretreated_cisplatin_refractory_germ_cell_tumors_Shiraishi T, Nakamura T, Mikami K, et al. 
Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors. [Journal Article]
Int J Clin Oncol 2009 Oct; 14(5):436-41.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19853437/full_citation/Prognostic_and_predictive_factors_for_outcome_to_first_line_ifosfamide_containing_chemotherapy_for_adult_patients_with_advanced_soft_tissue_sarcomas_An_exploratory_retrospective_analysis_on_large_series_from_the_European_Organization_for_Research_and_Treatment_of_Cancer_Soft_Tissue_and_Bone_Sarcoma_Group__EORTC_STBSG__Sleijfer S, Ouali M, van Glabbeke M, et al. 
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). [JOURNAL ARTICLE]
Eur J Cancer 2009 Oct 21.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19850470/full_citation/Persistent_nephrotoxicity_during_10_year_follow_up_after_cisplatin_or_carboplatin_treatment_in_childhood:_Relevance_of_age_and_dose_as_risk_factors_Skinner R, Parry A, Price L, et al. 
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors. [JOURNAL ARTICLE]
Eur J Cancer 2009 Oct 20.
Abstract | Full Citation | Find Related Articles